237 related articles for article (PubMed ID: 25889705)
1. Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose-response relationship of parotid-sparing radiotherapy in head-neck cancers.
Gupta T; Hotwani C; Kannan S; Master Z; Rangarajan V; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
Radiat Oncol; 2015 Mar; 10():67. PubMed ID: 25889705
[TBL] [Abstract][Full Text] [Related]
2. Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
Bussels B; Maes A; Flamen P; Lambin P; Erven K; Hermans R; Nuyts S; Weltens C; Cecere S; Lesaffre E; Van den Bogaert W
Radiother Oncol; 2004 Dec; 73(3):297-306. PubMed ID: 15588874
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
4. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.
Roesink JM; Moerland MA; Hoekstra A; Van Rijk PP; Terhaard CH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1451-60. PubMed ID: 15050323
[TBL] [Abstract][Full Text] [Related]
6. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
7. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.
Voordeckers M; Farrag A; Everaert H; Tournel K; Storme G; Verellen D; De Ridder M
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):443-8. PubMed ID: 22836056
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
[TBL] [Abstract][Full Text] [Related]
9. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland-sparing helical tomotherapy for head and neck cancer: Preserved salivary function on quantitative salivary gland scintigraphy after tomotherapy.
Kreps S; Berges O; Belin L; Zefkili S; Petras S; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Sep; 133(4):257-62. PubMed ID: 27291482
[TBL] [Abstract][Full Text] [Related]
12. Preservation of parotid function with uncomplicated conformal radiotherapy.
Maes A; Weltens C; Flamen P; Lambin P; Bogaerts R; Liu X; Baetens J; Hermans R; Van den Bogaert W
Radiother Oncol; 2002 May; 63(2):203-11. PubMed ID: 12063010
[TBL] [Abstract][Full Text] [Related]
13. Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study.
Murthy V; Lewis S; Kannan S; Khadanga CR; Rangarajan V; Joshi K; Gandhi M; Dey S; Rokde G; Budrukkar A; Gupta T; Laskar S; Agarwal JP
Radiother Oncol; 2018 Oct; 129(1):38-43. PubMed ID: 29724411
[TBL] [Abstract][Full Text] [Related]
14. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
15. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy.
Hsiung CY; Ting HM; Huang HY; Lee CH; Huang EY; Hsu HC
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):454-61. PubMed ID: 16839707
[TBL] [Abstract][Full Text] [Related]
16. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
Eisbruch A; Ten Haken RK; Kim HM; Marsh LH; Ship JA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):577-87. PubMed ID: 10524409
[TBL] [Abstract][Full Text] [Related]
17. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance.
Loutfi I; Nair MK; Ebrahim AK
J Nucl Med Technol; 2003 Jun; 31(2):81-5. PubMed ID: 12777459
[TBL] [Abstract][Full Text] [Related]
19. The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy.
van Acker F; Flamen P; Lambin P; Maes A; Kutcher GJ; Weltens C; Hermans R; Baetens J; Dupont P; Rijnders A; Maes A; van den Bogaert W; Mortelmans L
Nucl Med Commun; 2001 Feb; 22(2):225-31. PubMed ID: 11258410
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
